nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—SLCO2B1—Erlotinib—pancreatic cancer	0.22	0.301	CbGbCtD
Montelukast—CYP2A6—Tamoxifen—pancreatic cancer	0.115	0.157	CbGbCtD
Montelukast—CYP2A6—Fluorouracil—pancreatic cancer	0.0845	0.116	CbGbCtD
Montelukast—CYP2C8—Tamoxifen—pancreatic cancer	0.0565	0.0776	CbGbCtD
Montelukast—CYP2C8—Erlotinib—pancreatic cancer	0.0481	0.0659	CbGbCtD
Montelukast—CYP2C8—Fluorouracil—pancreatic cancer	0.0417	0.0572	CbGbCtD
Montelukast—CYP2C9—Tamoxifen—pancreatic cancer	0.0394	0.0541	CbGbCtD
Montelukast—CYP2C9—Fluorouracil—pancreatic cancer	0.0291	0.0399	CbGbCtD
Montelukast—CYP3A4—Tamoxifen—pancreatic cancer	0.0229	0.0315	CbGbCtD
Montelukast—CYP3A4—Erlotinib—pancreatic cancer	0.0195	0.0267	CbGbCtD
Montelukast—CYP3A4—Irinotecan—pancreatic cancer	0.0176	0.0242	CbGbCtD
Montelukast—CYP3A4—Docetaxel—pancreatic cancer	0.0129	0.0177	CbGbCtD
Montelukast—CYP3A4—Sunitinib—pancreatic cancer	0.0128	0.0176	CbGbCtD
Montelukast—CYP3A4—Doxorubicin—pancreatic cancer	0.00962	0.0132	CbGbCtD
Montelukast—Cardiac disorder—Docetaxel—pancreatic cancer	0.000329	0.00153	CcSEcCtD
Montelukast—Vomiting—Tamoxifen—pancreatic cancer	0.000328	0.00153	CcSEcCtD
Montelukast—Paraesthesia—Irinotecan—pancreatic cancer	0.000327	0.00152	CcSEcCtD
Montelukast—Hypersensitivity—Sunitinib—pancreatic cancer	0.000326	0.00151	CcSEcCtD
Montelukast—Rash—Tamoxifen—pancreatic cancer	0.000326	0.00151	CcSEcCtD
Montelukast—Dermatitis—Tamoxifen—pancreatic cancer	0.000325	0.00151	CcSEcCtD
Montelukast—Vomiting—Erlotinib—pancreatic cancer	0.000325	0.00151	CcSEcCtD
Montelukast—Somnolence—Irinotecan—pancreatic cancer	0.000324	0.0015	CcSEcCtD
Montelukast—Headache—Tamoxifen—pancreatic cancer	0.000323	0.0015	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000323	0.0015	CcSEcCtD
Montelukast—Rash—Erlotinib—pancreatic cancer	0.000322	0.0015	CcSEcCtD
Montelukast—Dermatitis—Erlotinib—pancreatic cancer	0.000322	0.0015	CcSEcCtD
Montelukast—Insomnia—Gemcitabine—pancreatic cancer	0.000321	0.00149	CcSEcCtD
Montelukast—Dyspepsia—Irinotecan—pancreatic cancer	0.000321	0.00149	CcSEcCtD
Montelukast—Immune system disorder—Docetaxel—pancreatic cancer	0.00032	0.00149	CcSEcCtD
Montelukast—Headache—Erlotinib—pancreatic cancer	0.00032	0.00149	CcSEcCtD
Montelukast—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000319	0.00148	CcSEcCtD
Montelukast—Paraesthesia—Gemcitabine—pancreatic cancer	0.000319	0.00148	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000318	0.00148	CcSEcCtD
Montelukast—Asthenia—Sunitinib—pancreatic cancer	0.000317	0.00147	CcSEcCtD
Montelukast—Insomnia—Fluorouracil—pancreatic cancer	0.000316	0.00147	CcSEcCtD
Montelukast—Somnolence—Gemcitabine—pancreatic cancer	0.000315	0.00147	CcSEcCtD
Montelukast—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000314	0.00146	CcSEcCtD
Montelukast—Fatigue—Irinotecan—pancreatic cancer	0.000314	0.00146	CcSEcCtD
Montelukast—Paraesthesia—Fluorouracil—pancreatic cancer	0.000313	0.00146	CcSEcCtD
Montelukast—Pruritus—Sunitinib—pancreatic cancer	0.000313	0.00145	CcSEcCtD
Montelukast—Pain—Irinotecan—pancreatic cancer	0.000312	0.00145	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000311	0.00145	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000311	0.00145	CcSEcCtD
Montelukast—Mental disorder—Docetaxel—pancreatic cancer	0.000311	0.00144	CcSEcCtD
Montelukast—Somnolence—Fluorouracil—pancreatic cancer	0.00031	0.00144	CcSEcCtD
Montelukast—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000309	0.00144	CcSEcCtD
Montelukast—Dyspepsia—Fluorouracil—pancreatic cancer	0.000307	0.00143	CcSEcCtD
Montelukast—Nausea—Tamoxifen—pancreatic cancer	0.000307	0.00143	CcSEcCtD
Montelukast—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000306	0.00142	CcSEcCtD
Montelukast—Fatigue—Gemcitabine—pancreatic cancer	0.000306	0.00142	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000305	0.00142	CcSEcCtD
Montelukast—Pain—Gemcitabine—pancreatic cancer	0.000303	0.00141	CcSEcCtD
Montelukast—Nausea—Erlotinib—pancreatic cancer	0.000303	0.00141	CcSEcCtD
Montelukast—Diarrhoea—Sunitinib—pancreatic cancer	0.000303	0.00141	CcSEcCtD
Montelukast—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000301	0.0014	CcSEcCtD
Montelukast—Asthma—Epirubicin—pancreatic cancer	0.000299	0.00139	CcSEcCtD
Montelukast—Influenza—Epirubicin—pancreatic cancer	0.000299	0.00139	CcSEcCtD
Montelukast—Pain—Fluorouracil—pancreatic cancer	0.000298	0.00139	CcSEcCtD
Montelukast—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000298	0.00138	CcSEcCtD
Montelukast—Muscle spasms—Docetaxel—pancreatic cancer	0.000297	0.00138	CcSEcCtD
Montelukast—Eosinophilia—Epirubicin—pancreatic cancer	0.000296	0.00137	CcSEcCtD
Montelukast—Pancreatitis—Epirubicin—pancreatic cancer	0.000293	0.00136	CcSEcCtD
Montelukast—Dizziness—Sunitinib—pancreatic cancer	0.000292	0.00136	CcSEcCtD
Montelukast—Body temperature increased—Irinotecan—pancreatic cancer	0.000288	0.00134	CcSEcCtD
Montelukast—Abdominal pain—Irinotecan—pancreatic cancer	0.000288	0.00134	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000288	0.00134	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000288	0.00134	CcSEcCtD
Montelukast—Bronchitis—Epirubicin—pancreatic cancer	0.000287	0.00133	CcSEcCtD
Montelukast—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000286	0.00133	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000282	0.00131	CcSEcCtD
Montelukast—Vomiting—Sunitinib—pancreatic cancer	0.000281	0.00131	CcSEcCtD
Montelukast—Body temperature increased—Gemcitabine—pancreatic cancer	0.000281	0.0013	CcSEcCtD
Montelukast—Rash—Sunitinib—pancreatic cancer	0.000279	0.0013	CcSEcCtD
Montelukast—Dermatitis—Sunitinib—pancreatic cancer	0.000279	0.00129	CcSEcCtD
Montelukast—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000278	0.00129	CcSEcCtD
Montelukast—Urticaria—Fluorouracil—pancreatic cancer	0.000277	0.00129	CcSEcCtD
Montelukast—Headache—Sunitinib—pancreatic cancer	0.000277	0.00129	CcSEcCtD
Montelukast—Asthma—Doxorubicin—pancreatic cancer	0.000276	0.00128	CcSEcCtD
Montelukast—Influenza—Doxorubicin—pancreatic cancer	0.000276	0.00128	CcSEcCtD
Montelukast—Body temperature increased—Fluorouracil—pancreatic cancer	0.000276	0.00128	CcSEcCtD
Montelukast—Eosinophilia—Doxorubicin—pancreatic cancer	0.000274	0.00127	CcSEcCtD
Montelukast—Palpitations—Docetaxel—pancreatic cancer	0.000273	0.00127	CcSEcCtD
Montelukast—Pancreatitis—Doxorubicin—pancreatic cancer	0.000271	0.00126	CcSEcCtD
Montelukast—Cough—Docetaxel—pancreatic cancer	0.000269	0.00125	CcSEcCtD
Montelukast—Hypersensitivity—Irinotecan—pancreatic cancer	0.000268	0.00125	CcSEcCtD
Montelukast—Pneumonia—Epirubicin—pancreatic cancer	0.000268	0.00124	CcSEcCtD
Montelukast—Convulsion—Docetaxel—pancreatic cancer	0.000267	0.00124	CcSEcCtD
Montelukast—Infestation NOS—Epirubicin—pancreatic cancer	0.000266	0.00124	CcSEcCtD
Montelukast—Infestation—Epirubicin—pancreatic cancer	0.000266	0.00124	CcSEcCtD
Montelukast—Drowsiness—Epirubicin—pancreatic cancer	0.000266	0.00124	CcSEcCtD
Montelukast—Bronchitis—Doxorubicin—pancreatic cancer	0.000266	0.00123	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000264	0.00123	CcSEcCtD
Montelukast—Arthralgia—Docetaxel—pancreatic cancer	0.000263	0.00122	CcSEcCtD
Montelukast—Myalgia—Docetaxel—pancreatic cancer	0.000263	0.00122	CcSEcCtD
Montelukast—Nausea—Sunitinib—pancreatic cancer	0.000263	0.00122	CcSEcCtD
Montelukast—Asthenia—Irinotecan—pancreatic cancer	0.000261	0.00121	CcSEcCtD
Montelukast—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000261	0.00121	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000261	0.00121	CcSEcCtD
Montelukast—Jaundice—Epirubicin—pancreatic cancer	0.00026	0.00121	CcSEcCtD
Montelukast—Conjunctivitis—Epirubicin—pancreatic cancer	0.000259	0.0012	CcSEcCtD
Montelukast—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000257	0.00119	CcSEcCtD
Montelukast—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000257	0.00119	CcSEcCtD
Montelukast—Asthenia—Gemcitabine—pancreatic cancer	0.000255	0.00118	CcSEcCtD
Montelukast—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000252	0.00117	CcSEcCtD
Montelukast—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000252	0.00117	CcSEcCtD
Montelukast—Oedema—Docetaxel—pancreatic cancer	0.000252	0.00117	CcSEcCtD
Montelukast—Epistaxis—Epirubicin—pancreatic cancer	0.000251	0.00117	CcSEcCtD
Montelukast—Pruritus—Gemcitabine—pancreatic cancer	0.000251	0.00117	CcSEcCtD
Montelukast—Infection—Docetaxel—pancreatic cancer	0.00025	0.00116	CcSEcCtD
Montelukast—Sinusitis—Epirubicin—pancreatic cancer	0.00025	0.00116	CcSEcCtD
Montelukast—Diarrhoea—Irinotecan—pancreatic cancer	0.000249	0.00116	CcSEcCtD
Montelukast—Pneumonia—Doxorubicin—pancreatic cancer	0.000248	0.00115	CcSEcCtD
Montelukast—Nervous system disorder—Docetaxel—pancreatic cancer	0.000247	0.00115	CcSEcCtD
Montelukast—Pruritus—Fluorouracil—pancreatic cancer	0.000247	0.00115	CcSEcCtD
Montelukast—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000247	0.00115	CcSEcCtD
Montelukast—Drowsiness—Doxorubicin—pancreatic cancer	0.000246	0.00114	CcSEcCtD
Montelukast—Infestation NOS—Doxorubicin—pancreatic cancer	0.000246	0.00114	CcSEcCtD
Montelukast—Infestation—Doxorubicin—pancreatic cancer	0.000246	0.00114	CcSEcCtD
Montelukast—Skin disorder—Docetaxel—pancreatic cancer	0.000245	0.00114	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000244	0.00114	CcSEcCtD
Montelukast—Diarrhoea—Gemcitabine—pancreatic cancer	0.000243	0.00113	CcSEcCtD
Montelukast—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000242	0.00112	CcSEcCtD
Montelukast—Dizziness—Irinotecan—pancreatic cancer	0.000241	0.00112	CcSEcCtD
Montelukast—Jaundice—Doxorubicin—pancreatic cancer	0.00024	0.00112	CcSEcCtD
Montelukast—Rhinitis—Epirubicin—pancreatic cancer	0.00024	0.00111	CcSEcCtD
Montelukast—Conjunctivitis—Doxorubicin—pancreatic cancer	0.00024	0.00111	CcSEcCtD
Montelukast—Hepatitis—Epirubicin—pancreatic cancer	0.000239	0.00111	CcSEcCtD
Montelukast—Diarrhoea—Fluorouracil—pancreatic cancer	0.000239	0.00111	CcSEcCtD
Montelukast—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000238	0.00111	CcSEcCtD
Montelukast—Pharyngitis—Epirubicin—pancreatic cancer	0.000237	0.0011	CcSEcCtD
Montelukast—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000236	0.0011	CcSEcCtD
Montelukast—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000235	0.00109	CcSEcCtD
Montelukast—Urethral disorder—Epirubicin—pancreatic cancer	0.000234	0.00109	CcSEcCtD
Montelukast—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000233	0.00108	CcSEcCtD
Montelukast—Epistaxis—Doxorubicin—pancreatic cancer	0.000232	0.00108	CcSEcCtD
Montelukast—Vomiting—Irinotecan—pancreatic cancer	0.000232	0.00108	CcSEcCtD
Montelukast—Sinusitis—Doxorubicin—pancreatic cancer	0.000231	0.00107	CcSEcCtD
Montelukast—Dizziness—Fluorouracil—pancreatic cancer	0.000231	0.00107	CcSEcCtD
Montelukast—Rash—Irinotecan—pancreatic cancer	0.00023	0.00107	CcSEcCtD
Montelukast—Dermatitis—Irinotecan—pancreatic cancer	0.000229	0.00107	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000229	0.00107	CcSEcCtD
Montelukast—Headache—Irinotecan—pancreatic cancer	0.000228	0.00106	CcSEcCtD
Montelukast—Insomnia—Docetaxel—pancreatic cancer	0.000228	0.00106	CcSEcCtD
Montelukast—Paraesthesia—Docetaxel—pancreatic cancer	0.000226	0.00105	CcSEcCtD
Montelukast—Erythema multiforme—Epirubicin—pancreatic cancer	0.000226	0.00105	CcSEcCtD
Montelukast—Vomiting—Gemcitabine—pancreatic cancer	0.000226	0.00105	CcSEcCtD
Montelukast—Somnolence—Docetaxel—pancreatic cancer	0.000224	0.00104	CcSEcCtD
Montelukast—Rash—Gemcitabine—pancreatic cancer	0.000224	0.00104	CcSEcCtD
Montelukast—Dermatitis—Gemcitabine—pancreatic cancer	0.000224	0.00104	CcSEcCtD
Montelukast—Headache—Gemcitabine—pancreatic cancer	0.000222	0.00103	CcSEcCtD
Montelukast—Cardiac disorder—Epirubicin—pancreatic cancer	0.000222	0.00103	CcSEcCtD
Montelukast—Vomiting—Fluorouracil—pancreatic cancer	0.000222	0.00103	CcSEcCtD
Montelukast—Rhinitis—Doxorubicin—pancreatic cancer	0.000222	0.00103	CcSEcCtD
Montelukast—Dyspepsia—Docetaxel—pancreatic cancer	0.000222	0.00103	CcSEcCtD
Montelukast—Hepatitis—Doxorubicin—pancreatic cancer	0.000221	0.00103	CcSEcCtD
Montelukast—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.00022	0.00102	CcSEcCtD
Montelukast—Rash—Fluorouracil—pancreatic cancer	0.00022	0.00102	CcSEcCtD
Montelukast—Dermatitis—Fluorouracil—pancreatic cancer	0.00022	0.00102	CcSEcCtD
Montelukast—Pharyngitis—Doxorubicin—pancreatic cancer	0.00022	0.00102	CcSEcCtD
Montelukast—Headache—Fluorouracil—pancreatic cancer	0.000219	0.00102	CcSEcCtD
Montelukast—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000218	0.00102	CcSEcCtD
Montelukast—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000217	0.00101	CcSEcCtD
Montelukast—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000217	0.00101	CcSEcCtD
Montelukast—Fatigue—Docetaxel—pancreatic cancer	0.000217	0.00101	CcSEcCtD
Montelukast—Urethral disorder—Doxorubicin—pancreatic cancer	0.000217	0.00101	CcSEcCtD
Montelukast—Nausea—Irinotecan—pancreatic cancer	0.000216	0.00101	CcSEcCtD
Montelukast—Immune system disorder—Epirubicin—pancreatic cancer	0.000216	0.001	CcSEcCtD
Montelukast—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000215	0.001	CcSEcCtD
Montelukast—Pain—Docetaxel—pancreatic cancer	0.000215	0.001	CcSEcCtD
Montelukast—Nausea—Gemcitabine—pancreatic cancer	0.000211	0.000979	CcSEcCtD
Montelukast—Mental disorder—Epirubicin—pancreatic cancer	0.000209	0.000973	CcSEcCtD
Montelukast—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000209	0.000972	CcSEcCtD
Montelukast—Nausea—Fluorouracil—pancreatic cancer	0.000207	0.000963	CcSEcCtD
Montelukast—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000206	0.000957	CcSEcCtD
Montelukast—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000205	0.000954	CcSEcCtD
Montelukast—Muscle spasms—Epirubicin—pancreatic cancer	0.0002	0.00093	CcSEcCtD
Montelukast—Immune system disorder—Doxorubicin—pancreatic cancer	0.0002	0.000928	CcSEcCtD
Montelukast—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000199	0.000926	CcSEcCtD
Montelukast—Body temperature increased—Docetaxel—pancreatic cancer	0.000199	0.000925	CcSEcCtD
Montelukast—Abdominal pain—Docetaxel—pancreatic cancer	0.000199	0.000925	CcSEcCtD
Montelukast—Mental disorder—Doxorubicin—pancreatic cancer	0.000194	0.0009	CcSEcCtD
Montelukast—Agitation—Epirubicin—pancreatic cancer	0.000191	0.000889	CcSEcCtD
Montelukast—Hypersensitivity—Docetaxel—pancreatic cancer	0.000186	0.000862	CcSEcCtD
Montelukast—Muscle spasms—Doxorubicin—pancreatic cancer	0.000185	0.00086	CcSEcCtD
Montelukast—Palpitations—Epirubicin—pancreatic cancer	0.000184	0.000855	CcSEcCtD
Montelukast—Cough—Epirubicin—pancreatic cancer	0.000182	0.000844	CcSEcCtD
Montelukast—Asthenia—Docetaxel—pancreatic cancer	0.000181	0.000839	CcSEcCtD
Montelukast—Convulsion—Epirubicin—pancreatic cancer	0.00018	0.000838	CcSEcCtD
Montelukast—Pruritus—Docetaxel—pancreatic cancer	0.000178	0.000828	CcSEcCtD
Montelukast—Arthralgia—Epirubicin—pancreatic cancer	0.000177	0.000823	CcSEcCtD
Montelukast—Myalgia—Epirubicin—pancreatic cancer	0.000177	0.000823	CcSEcCtD
Montelukast—Agitation—Doxorubicin—pancreatic cancer	0.000177	0.000822	CcSEcCtD
Montelukast—Anxiety—Epirubicin—pancreatic cancer	0.000177	0.00082	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000176	0.000818	CcSEcCtD
Montelukast—Diarrhoea—Docetaxel—pancreatic cancer	0.000172	0.000801	CcSEcCtD
Montelukast—Palpitations—Doxorubicin—pancreatic cancer	0.00017	0.000791	CcSEcCtD
Montelukast—Anaphylactic shock—Epirubicin—pancreatic cancer	0.00017	0.000789	CcSEcCtD
Montelukast—Oedema—Epirubicin—pancreatic cancer	0.00017	0.000789	CcSEcCtD
Montelukast—Infection—Epirubicin—pancreatic cancer	0.000169	0.000784	CcSEcCtD
Montelukast—Cough—Doxorubicin—pancreatic cancer	0.000168	0.000781	CcSEcCtD
Montelukast—Convulsion—Doxorubicin—pancreatic cancer	0.000167	0.000775	CcSEcCtD
Montelukast—Nervous system disorder—Epirubicin—pancreatic cancer	0.000167	0.000774	CcSEcCtD
Montelukast—Dizziness—Docetaxel—pancreatic cancer	0.000167	0.000774	CcSEcCtD
Montelukast—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000166	0.000773	CcSEcCtD
Montelukast—Skin disorder—Epirubicin—pancreatic cancer	0.000165	0.000767	CcSEcCtD
Montelukast—Myalgia—Doxorubicin—pancreatic cancer	0.000164	0.000762	CcSEcCtD
Montelukast—Arthralgia—Doxorubicin—pancreatic cancer	0.000164	0.000762	CcSEcCtD
Montelukast—Anxiety—Doxorubicin—pancreatic cancer	0.000163	0.000759	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000163	0.000756	CcSEcCtD
Montelukast—Vomiting—Docetaxel—pancreatic cancer	0.00016	0.000744	CcSEcCtD
Montelukast—Rash—Docetaxel—pancreatic cancer	0.000159	0.000738	CcSEcCtD
Montelukast—Dermatitis—Docetaxel—pancreatic cancer	0.000159	0.000737	CcSEcCtD
Montelukast—Headache—Docetaxel—pancreatic cancer	0.000158	0.000733	CcSEcCtD
Montelukast—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000157	0.00073	CcSEcCtD
Montelukast—Oedema—Doxorubicin—pancreatic cancer	0.000157	0.00073	CcSEcCtD
Montelukast—Infection—Doxorubicin—pancreatic cancer	0.000156	0.000725	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000155	0.000719	CcSEcCtD
Montelukast—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000154	0.000716	CcSEcCtD
Montelukast—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000154	0.000715	CcSEcCtD
Montelukast—Insomnia—Epirubicin—pancreatic cancer	0.000154	0.000714	CcSEcCtD
Montelukast—Skin disorder—Doxorubicin—pancreatic cancer	0.000153	0.000709	CcSEcCtD
Montelukast—Paraesthesia—Epirubicin—pancreatic cancer	0.000153	0.000709	CcSEcCtD
Montelukast—Somnolence—Epirubicin—pancreatic cancer	0.000151	0.000702	CcSEcCtD
Montelukast—Nausea—Docetaxel—pancreatic cancer	0.00015	0.000695	CcSEcCtD
Montelukast—Dyspepsia—Epirubicin—pancreatic cancer	0.00015	0.000695	CcSEcCtD
Montelukast—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000147	0.000681	CcSEcCtD
Montelukast—Fatigue—Epirubicin—pancreatic cancer	0.000146	0.00068	CcSEcCtD
Montelukast—Pain—Epirubicin—pancreatic cancer	0.000145	0.000675	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000143	0.000665	CcSEcCtD
Montelukast—Insomnia—Doxorubicin—pancreatic cancer	0.000142	0.00066	CcSEcCtD
Montelukast—Paraesthesia—Doxorubicin—pancreatic cancer	0.000141	0.000656	CcSEcCtD
Montelukast—Somnolence—Doxorubicin—pancreatic cancer	0.00014	0.000649	CcSEcCtD
Montelukast—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000139	0.000645	CcSEcCtD
Montelukast—Dyspepsia—Doxorubicin—pancreatic cancer	0.000138	0.000643	CcSEcCtD
Montelukast—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000136	0.00063	CcSEcCtD
Montelukast—Fatigue—Doxorubicin—pancreatic cancer	0.000135	0.00063	CcSEcCtD
Montelukast—Urticaria—Epirubicin—pancreatic cancer	0.000135	0.000627	CcSEcCtD
Montelukast—Pain—Doxorubicin—pancreatic cancer	0.000134	0.000624	CcSEcCtD
Montelukast—Abdominal pain—Epirubicin—pancreatic cancer	0.000134	0.000624	CcSEcCtD
Montelukast—Body temperature increased—Epirubicin—pancreatic cancer	0.000134	0.000624	CcSEcCtD
Montelukast—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000129	0.000597	CcSEcCtD
Montelukast—ALOX5—Metabolism—PRSS1—pancreatic cancer	0.000128	0.00228	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—IAPP—pancreatic cancer	0.000126	0.00226	CbGpPWpGaD
Montelukast—Hypersensitivity—Epirubicin—pancreatic cancer	0.000125	0.000581	CcSEcCtD
Montelukast—Urticaria—Doxorubicin—pancreatic cancer	0.000125	0.00058	CcSEcCtD
Montelukast—CYSLTR1—Signaling Pathways—DTX1—pancreatic cancer	0.000125	0.00223	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—SSTR3—pancreatic cancer	0.000125	0.00223	CbGpPWpGaD
Montelukast—Body temperature increased—Doxorubicin—pancreatic cancer	0.000124	0.000577	CcSEcCtD
Montelukast—Abdominal pain—Doxorubicin—pancreatic cancer	0.000124	0.000577	CcSEcCtD
Montelukast—CYSLTR1—GPCR downstream signaling—SST—pancreatic cancer	0.000122	0.00218	CbGpPWpGaD
Montelukast—Asthenia—Epirubicin—pancreatic cancer	0.000122	0.000566	CcSEcCtD
Montelukast—CYSLTR1—Signaling by GPCR—PTHLH—pancreatic cancer	0.000121	0.00217	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—PTCH1—pancreatic cancer	0.000121	0.00217	CbGpPWpGaD
Montelukast—Pruritus—Epirubicin—pancreatic cancer	0.00012	0.000558	CcSEcCtD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	0.00012	0.00214	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—SSTR1—pancreatic cancer	0.00012	0.00214	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PPY—pancreatic cancer	0.000117	0.0021	CbGpPWpGaD
Montelukast—Diarrhoea—Epirubicin—pancreatic cancer	0.000116	0.00054	CcSEcCtD
Montelukast—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000116	0.000538	CcSEcCtD
Montelukast—CYSLTR1—Signaling Pathways—SSTR2—pancreatic cancer	0.000115	0.00206	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—CNR1—pancreatic cancer	0.000113	0.00201	CbGpPWpGaD
Montelukast—Asthenia—Doxorubicin—pancreatic cancer	0.000113	0.000524	CcSEcCtD
Montelukast—Dizziness—Epirubicin—pancreatic cancer	0.000112	0.000522	CcSEcCtD
Montelukast—CYSLTR1—Signaling Pathways—CCKBR—pancreatic cancer	0.000111	0.00199	CbGpPWpGaD
Montelukast—Pruritus—Doxorubicin—pancreatic cancer	0.000111	0.000517	CcSEcCtD
Montelukast—CYSLTR1—Signaling by GPCR—SST—pancreatic cancer	0.000111	0.00198	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—ARG2—pancreatic cancer	0.000111	0.00198	CbGpPWpGaD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000111	0.00198	CbGpPWpGaD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	0.000109	0.00195	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—GCG—pancreatic cancer	0.000109	0.00195	CbGpPWpGaD
Montelukast—Vomiting—Epirubicin—pancreatic cancer	0.000108	0.000502	CcSEcCtD
Montelukast—Diarrhoea—Doxorubicin—pancreatic cancer	0.000108	0.0005	CcSEcCtD
Montelukast—CYP2C8—Arachidonic acid metabolism—PTGS2—pancreatic cancer	0.000107	0.00192	CbGpPWpGaD
Montelukast—Rash—Epirubicin—pancreatic cancer	0.000107	0.000498	CcSEcCtD
Montelukast—Dermatitis—Epirubicin—pancreatic cancer	0.000107	0.000497	CcSEcCtD
Montelukast—Headache—Epirubicin—pancreatic cancer	0.000106	0.000494	CcSEcCtD
Montelukast—CYSLTR1—G alpha (q) signalling events—PIK3CA—pancreatic cancer	0.000106	0.00189	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—PTGS2—pancreatic cancer	0.000106	0.00189	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—GLI1—pancreatic cancer	0.000105	0.00187	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—DTX4—pancreatic cancer	0.000105	0.00187	CbGpPWpGaD
Montelukast—Dizziness—Doxorubicin—pancreatic cancer	0.000104	0.000483	CcSEcCtD
Montelukast—CYSLTR1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000104	0.00186	CbGpPWpGaD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	0.000103	0.00184	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—CNR1—pancreatic cancer	0.000102	0.00183	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NRP1—pancreatic cancer	0.000102	0.00182	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000102	0.00182	CbGpPWpGaD
Montelukast—Nausea—Epirubicin—pancreatic cancer	0.000101	0.000469	CcSEcCtD
Montelukast—Vomiting—Doxorubicin—pancreatic cancer	9.99e-05	0.000464	CcSEcCtD
Montelukast—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	9.98e-05	0.00178	CbGpPWpGaD
Montelukast—Rash—Doxorubicin—pancreatic cancer	9.91e-05	0.00046	CcSEcCtD
Montelukast—Dermatitis—Doxorubicin—pancreatic cancer	9.9e-05	0.00046	CcSEcCtD
Montelukast—CYSLTR1—Signaling by GPCR—GCG—pancreatic cancer	9.89e-05	0.00177	CbGpPWpGaD
Montelukast—Headache—Doxorubicin—pancreatic cancer	9.85e-05	0.000457	CcSEcCtD
Montelukast—CYSLTR1—Signaling Pathways—HEY2—pancreatic cancer	9.79e-05	0.00175	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—TYMP—pancreatic cancer	9.69e-05	0.00173	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—GAST—pancreatic cancer	9.57e-05	0.00171	CbGpPWpGaD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	9.48e-05	0.00169	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—AGTR1—pancreatic cancer	9.44e-05	0.00169	CbGpPWpGaD
Montelukast—Nausea—Doxorubicin—pancreatic cancer	9.33e-05	0.000434	CcSEcCtD
Montelukast—CYSLTR1—Signaling Pathways—SCT—pancreatic cancer	9.07e-05	0.00162	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—HEY1—pancreatic cancer	9.07e-05	0.00162	CbGpPWpGaD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	8.77e-05	0.00157	CbGpPWpGaD
Montelukast—CYP2C9—Arachidonic acid metabolism—PTGS2—pancreatic cancer	8.74e-05	0.00156	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CCK—pancreatic cancer	8.65e-05	0.00154	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CNR2—pancreatic cancer	8.43e-05	0.00151	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—GLP1R—pancreatic cancer	8.43e-05	0.00151	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR ligand binding—CXCL8—pancreatic cancer	8.42e-05	0.0015	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CCKAR—pancreatic cancer	8.29e-05	0.00148	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—JAG2—pancreatic cancer	8.04e-05	0.00144	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	8e-05	0.00143	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MEN1—pancreatic cancer	7.93e-05	0.00142	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—GLP1R—pancreatic cancer	7.81e-05	0.0014	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—DPYD—pancreatic cancer	7.69e-05	0.00137	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—SHH—pancreatic cancer	7.56e-05	0.00135	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NOTCH4—pancreatic cancer	7.51e-05	0.00134	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IAPP—pancreatic cancer	7.47e-05	0.00133	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—SLC2A2—pancreatic cancer	7.29e-05	0.0013	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.22e-05	0.00129	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PTHLH—pancreatic cancer	7.17e-05	0.00128	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PTCH1—pancreatic cancer	7.17e-05	0.00128	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—TNF—pancreatic cancer	7.14e-05	0.00128	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.97e-05	0.00124	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—SST—pancreatic cancer	6.56e-05	0.00117	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—PIK3CG—pancreatic cancer	6.47e-05	0.00115	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—JAG1—pancreatic cancer	6.42e-05	0.00115	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NOTCH3—pancreatic cancer	6.39e-05	0.00114	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.35e-05	0.00113	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CNR1—pancreatic cancer	6.05e-05	0.00108	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—PIK3CG—pancreatic cancer	5.87e-05	0.00105	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—GCG—pancreatic cancer	5.84e-05	0.00104	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—PIK3CD—pancreatic cancer	5.68e-05	0.00102	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—CD44—pancreatic cancer	5.65e-05	0.00101	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—AGTR1—pancreatic cancer	5.57e-05	0.000995	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PRSS1—pancreatic cancer	5.55e-05	0.00099	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.53e-05	0.000988	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—STK11—pancreatic cancer	5.49e-05	0.000981	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.48e-05	0.000979	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—GCG—pancreatic cancer	5.42e-05	0.000967	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PRSS1—pancreatic cancer	5.24e-05	0.000937	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—PIK3CD—pancreatic cancer	5.16e-05	0.000922	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—STK11—pancreatic cancer	5.09e-05	0.000909	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.95e-05	0.000885	CbGpPWpGaD
Montelukast—CYP2A6—NRF2 pathway—TGFB1—pancreatic cancer	4.82e-05	0.000861	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—SMAD4—pancreatic cancer	4.81e-05	0.000859	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ARG2—pancreatic cancer	4.81e-05	0.000859	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.78e-05	0.000854	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—CXCL8—pancreatic cancer	4.76e-05	0.00085	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—HES1—pancreatic cancer	4.7e-05	0.000839	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ARG2—pancreatic cancer	4.55e-05	0.000812	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—PIK3CB—pancreatic cancer	4.5e-05	0.000803	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—TYMS—pancreatic cancer	4.38e-05	0.000782	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—CXCL8—pancreatic cancer	4.32e-05	0.000772	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—TYMP—pancreatic cancer	4.2e-05	0.000751	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TERT—pancreatic cancer	4.12e-05	0.000735	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—TYMP—pancreatic cancer	3.97e-05	0.00071	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—HIF1A—pancreatic cancer	3.94e-05	0.000703	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TSC2—pancreatic cancer	3.93e-05	0.000701	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—APOE—pancreatic cancer	3.84e-05	0.000686	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—KDR—pancreatic cancer	3.77e-05	0.000672	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PRSS1—pancreatic cancer	3.58e-05	0.00064	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NFKBIA—pancreatic cancer	3.58e-05	0.00064	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—APOE—pancreatic cancer	3.56e-05	0.000636	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NOTCH1—pancreatic cancer	3.55e-05	0.000633	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PIK3CG—pancreatic cancer	3.47e-05	0.000619	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.47e-05	0.000619	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—NRAS—pancreatic cancer	3.47e-05	0.000619	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—EGF—pancreatic cancer	3.43e-05	0.000612	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GLP1R—pancreatic cancer	3.39e-05	0.000605	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.37e-05	0.000602	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—DPYD—pancreatic cancer	3.33e-05	0.000595	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3CG—pancreatic cancer	3.22e-05	0.000574	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GLP1R—pancreatic cancer	3.2e-05	0.000572	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—SLC2A2—pancreatic cancer	3.16e-05	0.000565	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—EGFR—pancreatic cancer	3.16e-05	0.000564	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—DPYD—pancreatic cancer	3.15e-05	0.000563	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.13e-05	0.000559	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ARG2—pancreatic cancer	3.11e-05	0.000555	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PPARG—pancreatic cancer	3.1e-05	0.000554	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PIK3CD—pancreatic cancer	3.05e-05	0.000545	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.02e-05	0.00054	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.02e-05	0.000539	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—SLC2A2—pancreatic cancer	2.99e-05	0.000534	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—KRAS—pancreatic cancer	2.99e-05	0.000533	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PRSS1—pancreatic cancer	2.92e-05	0.000521	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3CD—pancreatic cancer	2.83e-05	0.000505	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.75e-05	0.000491	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—PIK3CA—pancreatic cancer	2.74e-05	0.00049	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—TYMP—pancreatic cancer	2.72e-05	0.000485	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PIK3CB—pancreatic cancer	2.66e-05	0.000475	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CXCL8—pancreatic cancer	2.55e-05	0.000456	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—HRAS—pancreatic cancer	2.54e-05	0.000453	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ARG2—pancreatic cancer	2.53e-05	0.000451	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—AKT1—pancreatic cancer	2.47e-05	0.000441	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3CB—pancreatic cancer	2.46e-05	0.00044	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CD44—pancreatic cancer	2.45e-05	0.000437	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CASP3—pancreatic cancer	2.44e-05	0.000437	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PTGS2—pancreatic cancer	2.44e-05	0.000436	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.4e-05	0.000428	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CCND1—pancreatic cancer	2.38e-05	0.000425	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.38e-05	0.000424	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CTNNB1—pancreatic cancer	2.36e-05	0.000421	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GCG—pancreatic cancer	2.35e-05	0.000419	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CD44—pancreatic cancer	2.32e-05	0.000414	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MMP9—pancreatic cancer	2.31e-05	0.000413	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PTEN—pancreatic cancer	2.3e-05	0.00041	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—AKT1—pancreatic cancer	2.24e-05	0.0004	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.24e-05	0.0004	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GCG—pancreatic cancer	2.22e-05	0.000397	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—TYMP—pancreatic cancer	2.21e-05	0.000395	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—STK11—pancreatic cancer	2.21e-05	0.000394	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GLP1R—pancreatic cancer	2.19e-05	0.000391	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—DPYD—pancreatic cancer	2.15e-05	0.000384	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—SRC—pancreatic cancer	2.13e-05	0.00038	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PTEN—pancreatic cancer	2.13e-05	0.00038	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—STK11—pancreatic cancer	2.09e-05	0.000373	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—VEGFA—pancreatic cancer	2.07e-05	0.00037	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.07e-05	0.00037	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—STAT3—pancreatic cancer	2.05e-05	0.000367	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NRAS—pancreatic cancer	2.05e-05	0.000366	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	2.04e-05	0.000365	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.02e-05	0.000361	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.95e-05	0.000348	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.92e-05	0.000343	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MYC—pancreatic cancer	1.91e-05	0.000341	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TGFB1—pancreatic cancer	1.9e-05	0.00034	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—TYMS—pancreatic cancer	1.9e-05	0.000339	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—EGFR—pancreatic cancer	1.87e-05	0.000333	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.82e-05	0.000326	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—TYMS—pancreatic cancer	1.8e-05	0.000321	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GLP1R—pancreatic cancer	1.78e-05	0.000318	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.78e-05	0.000317	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—KRAS—pancreatic cancer	1.76e-05	0.000315	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—DPYD—pancreatic cancer	1.75e-05	0.000313	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.67e-05	0.000298	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	1.66e-05	0.000297	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.65e-05	0.000294	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PIK3CA—pancreatic cancer	1.62e-05	0.000289	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.59e-05	0.000284	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CD44—pancreatic cancer	1.58e-05	0.000283	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TP53—pancreatic cancer	1.57e-05	0.00028	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.55e-05	0.000277	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—APOE—pancreatic cancer	1.54e-05	0.000276	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.54e-05	0.000274	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GCG—pancreatic cancer	1.52e-05	0.000271	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3CA—pancreatic cancer	1.5e-05	0.000268	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—HRAS—pancreatic cancer	1.5e-05	0.000268	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.46e-05	0.000261	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—APOE—pancreatic cancer	1.46e-05	0.000261	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.46e-05	0.00026	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.45e-05	0.000258	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—STK11—pancreatic cancer	1.43e-05	0.000255	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CG—pancreatic cancer	1.39e-05	0.000249	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PPARG—pancreatic cancer	1.35e-05	0.00024	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.34e-05	0.000239	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—AKT1—pancreatic cancer	1.32e-05	0.000236	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CG—pancreatic cancer	1.32e-05	0.000235	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CD44—pancreatic cancer	1.29e-05	0.00023	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PPARG—pancreatic cancer	1.27e-05	0.000227	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.26e-05	0.000225	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.25e-05	0.000223	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GCG—pancreatic cancer	1.23e-05	0.00022	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—TYMS—pancreatic cancer	1.23e-05	0.000219	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—AKT1—pancreatic cancer	1.23e-05	0.000219	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CD—pancreatic cancer	1.23e-05	0.000219	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.17e-05	0.00021	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—STK11—pancreatic cancer	1.16e-05	0.000207	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CD—pancreatic cancer	1.16e-05	0.000207	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.16e-05	0.000206	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.1e-05	0.000196	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.09e-05	0.000195	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CB—pancreatic cancer	1.07e-05	0.000191	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PTGS2—pancreatic cancer	1.06e-05	0.000189	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CB—pancreatic cancer	1.01e-05	0.00018	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PTGS2—pancreatic cancer	1e-05	0.000179	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—TYMS—pancreatic cancer	9.99e-06	0.000178	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—APOE—pancreatic cancer	9.98e-06	0.000178	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	9.44e-06	0.000169	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PTEN—pancreatic cancer	9.23e-06	0.000165	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	9e-06	0.000161	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PTEN—pancreatic cancer	8.73e-06	0.000156	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PPARG—pancreatic cancer	8.69e-06	0.000155	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CD44—pancreatic cancer	8.49e-06	0.000152	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GCG—pancreatic cancer	8.14e-06	0.000145	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—APOE—pancreatic cancer	8.12e-06	0.000145	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	7.92e-06	0.000141	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	7.69e-06	0.000137	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—STK11—pancreatic cancer	7.66e-06	0.000137	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	7.33e-06	0.000131	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PPARG—pancreatic cancer	7.07e-06	0.000126	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	6.9e-06	0.000123	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PTGS2—pancreatic cancer	6.84e-06	0.000122	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—TYMS—pancreatic cancer	6.59e-06	0.000118	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CA—pancreatic cancer	6.51e-06	0.000116	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	6.44e-06	0.000115	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CA—pancreatic cancer	6.16e-06	0.00011	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PTEN—pancreatic cancer	5.96e-06	0.000106	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	5.62e-06	0.0001	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PTGS2—pancreatic cancer	5.56e-06	9.94e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—APOE—pancreatic cancer	5.36e-06	9.56e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—AKT1—pancreatic cancer	5.32e-06	9.5e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—AKT1—pancreatic cancer	5.03e-06	8.98e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PTEN—pancreatic cancer	4.85e-06	8.67e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	4.83e-06	8.63e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PPARG—pancreatic cancer	4.66e-06	8.33e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	4.25e-06	7.59e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	4.21e-06	7.51e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.7e-06	6.61e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.67e-06	6.55e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—AKT1—pancreatic cancer	3.44e-06	6.14e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	3.42e-06	6.11e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.2e-06	5.72e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—AKT1—pancreatic cancer	2.8e-06	4.99e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.26e-06	4.03e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.84e-06	3.29e-05	CbGpPWpGaD
